Groupe Bioclinic
FranceWho owns Groupe Bioclinic?
Groupe Bioclinic is a French HealthTech company, now owned by Inovie, which acquired it in 2022 from Idia and Socadif.
Hand-verified · updated 2026-05-07
Open JSON · CC-BY
- ·Fully exited in 2022 to Inovie.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
Idia sold GROUPE BIOCLINIC to Inovie in 2022 after 3 years.
Socadif sold Groupe Bioclinic to Inovie in 2022 after 3 years.
More from SOCADIF
Other portfolio companies in the same fund.
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
UK
US
Questions
Who owns Groupe Bioclinic?
Groupe Bioclinic is now owned by Inovie, which acquired it in 2022 from Idia and Socadif.
When did Inovie acquire Groupe Bioclinic?
Inovie acquired Groupe Bioclinic in 2022, buying from Idia and Socadif.
Who did Groupe Bioclinic sell to?
Idia and Socadif sold Groupe Bioclinic to Inovie in 2022 (Trade Sale).
Who has owned Groupe Bioclinic over time?
Groupe Bioclinic has been through 2 private-equity ownership periods: Idia · via IDIA Small & Midcap · 2019–2022 · sold to Inovie · (Trade Sale); Socadif · via SOCADIF · 2019–2022 · sold to Inovie · (Trade Sale).